MCAZ bans the sale of Benylin paediatric syrup

Zim Now Writer

The Medicines Control Authority of Zimbabwe has recalled two Benylin Paediatric batches following tests done by the National Agency for Food and Drug Administration that found high levels of Diethylene glycol.

The two condemned batches, 329303 and 329304, have toxic effects that include abdominal pain, vomiting, diarrhoea among others that potentially lead to death, with authorities on the lookout for smuggled batches which might have found their way into the Zimbabwean market.

In a statement, MCAZ Director-General, Richard Rukwata, warned the public to desist from giving the medicine to children, while encouraging them to purchase medicine from approved and professional pharmacies.

“While the Authority confirms that this product was registered in 2023 for use in Zimbabwe, our import database does not show a record of the importation of this product and more specifically these two batches.

“However, there is a concern that through illegal means, the aforementioned batches of Benylin Paediatric Syrup may find their way into the local market. As a precautionary measure, the Authority is issuing a recall notice for this product.

“In the unlikely event that members of the public are in possession of and/or come across this product, please notify the Authority and/or healthcare provider immediately and desist from administering them to children,” Rukwata said.

The Authority has urged members of the public to access medicines from licenced persons and premises for easier monitoring.

He also noted that his organisation is increasing surveillance through monitoring medicine premises and intensifying public awareness against circulation of the condemned product.

“The cooperation of all stakeholders is essential in ensuring the right of citizens to safe and good quality medicines is protected.

“Meanwhile, the Authority will intensify its market surveillance activities through strict premises inspections and public awareness to ensure that these products are not circulated.

“The mandate of the MCAZ is to protect public health by ensuring that all medicines and medical devices on the market are safe, effective, and of good quality and will continue to monitor the situation in line with the WHO guidelines.

“The Authority and law enforcement agencies continue to work together to eradicate any substandard and falsified health products, " Rukwata added.